As known as common polymorphisms in this gene could affect plasma HDL-C levels and the risk of atherosclerosis and CAD[28-30], dysregulation of ABCA1 expression may be a central mediator of AD neuropathology and dementia severity[31]. This evidence concerns the gene ABCA1 and atherosclerosis.